Metabolic disorders in polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pediatric Endocrinology Diabetes and Metabolism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.18544/PEDM-23.04.0094PMID 29574473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

  2014cited by this paper
• The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.

  2014cited by this paper
• Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS)

  2014cited by this paper
• Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring.

  2013cited by this paper
• Ontogeny of the ovary in polycystic ovary syndrome.

  2013cited by this paper
• Association of anthropometric, androgenic and insulin-related features with polymorphisms in exon 8 of SHBG gene in women with polycystic ovary syndrome

  2013cited by this paper
• Polycystic Ovary Syndrome: Is Obesity a Symptom?

  2013cited by this paper
• Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause

  2013cited by this paper
• Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

  2013cited by this paper
• Placental steroidogenesis in pregnant women with polycystic ovary syndrome.

  2013cited by this paper
• Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women.

  2013cited by this paper
• Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.

  2013cited by this paper
• The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review.

  2013cited by this paper
• Seasonal effects on vitamin D status influence outcomes of lifestyle intervention in overweight and obese women with polycystic ovary syndrome.

  2013cited by this paper
• The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis

  2013cited by this paper
• Renaming PCOS--a two-state solution.

  2013cited by this paper
• Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.

  2013cited by this paper
• The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.

  2013cited by this paper
• Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

  2013cited by this paper
• Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.

  2012cited by this paper
• Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features

  2012cited by this paper
• Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome.

  2012cited by this paper
• Does PCOS have developmental origins?

  2012cited by this paper
• Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

  2012cited by this paper
• Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.

  2011cited by this paper
• Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander?

  2011cited by this paper
• Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.

  2011cited by this paper
• Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.

  2011cited by this paper
• Adipose Tissue Dysfunction in Polycystic Ovary Syndrome

  2011cited by this paper
• The role of low-grade inflammation in the polycystic ovary syndrome.

  2011cited by this paper
• Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.

  2011cited by this paper
• Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.

  2011cited by this paper
• High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.

  2010cited by this paper
• Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.

  2010cited by this paper
• Statins: Do they have potential in the treatment of polycystic ovary syndrome?

  2010cited by this paper
• Quantitative analysis of antral follicle number and size: a comparison of two‐dimensional and automated three‐dimensional ultrasound techniques

  2010cited by this paper
• Vitamin D Regulates Anti-Mullerian Hormone Expression in Granulosa Cells of the Hen1

  2010cited by this paper
• Adipose tissue expandability and the early origins of PCOS.

  2009cited by this paper
• Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

  2008cited by this paper
• Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome.

  2007cited by this paper
• Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study.

  2007cited by this paper
• Polycystic ovary syndrome and its developmental origins

  2007cited by this paper
• Inflammatory and endothelial markers in women with polycystic ovary syndrome

  2006cited by this paper
• Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

  2005cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

  2002cited by this paper
• Endocrine consequences of premature pubarche in post‐pubertal Caucasian girls

  2002cited by this paper
• Altered vascular function in young women with polycystic ovary syndrome.

  2002cited by this paper
• Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: From a complex constellation to a simple sequence of prenatal onset

  1998cited by this paper
• Testosterone increases lipolysis and the number of beta-adrenoceptors in male rat adipocytes.

  1991cited by this paper

• Quality of Life of Women with Polycystic Ovary Syndrome

  2024cites this paper
• Effect of vitamin D on pregnancy in women with polycystic ovary syndrome: retrospective and prospective studies.

  2024cites this paper
• Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): A Multifaceted Hypothesis Towards the Disease with Potential Therapeutics

  2023cites this paper
• Expression and Contribution of Insulin Signaling Pathway to the Development of Polycystic Ovary Syndrome

  2023cites this paper
• Distinctions in PCOS induced by letrozole versus dehydroepiandrosterone with high-fat diet in mouse model.

  2022cites this paper
• 25(OH)VitD and human endocrine and functional fertility parameters in women undergoing IVF/ICSI

  2022cites this paper
• Polycystic ovary syndrome and obesity: a modern paradigm

  2022cites this paper
• GIMAP7 induces oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inhibiting sonic hedgehog signalling pathway

  2022cites this paper
• Drug discovery and potential gene and pathway associated with polycystic ovary syndrome through text mining and biomedical databases

  2022cites this paper
• Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis

  2022cites this paper
• Circ_0005925 Promotes Granulosa Cell Growth by Targeting MiR-324-3p to Upregulate MAP2K6 in Polycystic Ovary Syndrome

  2022cites this paper
• Polycystic Ovary Syndrome: Insights from Preclinical Research.

  2022cites this paper
• The influence of diet on polycystic ovary syndrome

  2021cites this paper
• Investigation of common risk factors between polycystic ovary syndrome and Alzheimer’s disease: a narrative review

  2021cites this paper
• Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.

  2019cites this paper
• Expression and Contribution of Insulin Signaling Pathway to the Development of Polycystic Ovary Syndrome

  2019cites this paper